The Current and Future State of Microbiome Therapeutics in Liver Disease
Author:
Affiliation:
1. University of Michigan, Ann Arbor, Michigan, USA;
2. Virginia Commonwealth University and Richmond VA Medical Center, Richmond, Virginia, USA.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Gastroenterology,Hepatology
Reference85 articles.
1. Interplay between the human gut microbiome and host metabolism;Visconti;Nat Commun,2019
2. Macronutrient metabolism by the human gut microbiome: Major fermentation by-products and their impact on host health;Oliphant;Microbiome,2019
3. Gut microbiome, liver immunology, and liver diseases;Wang;Cell Mol Immunol,2021
4. Bile acids as modulators of gut microbiota composition and function;Larabi;Gut Microbes,2023
5. Gut microbiome-based metagenomic signature for non-invasive detection of advanced fibrosis in human nonalcoholic fatty liver disease;Loomba;Cell Metab,2017
Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Gut microbiome profiles to exclude the diagnosis of hepatic encephalopathy in patients with cirrhosis;Gut Microbes;2024-08-27
2. Therapeutic manipulation of the microbiome in liver disease;Hepatology;2024-06-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3